BOREA, Pier Andrea
 Distribuzione geografica
Continente #
NA - Nord America 44.751
AS - Asia 21.885
EU - Europa 16.253
SA - Sud America 3.503
AF - Africa 316
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 30
Totale 86.771
Nazione #
US - Stati Uniti d'America 43.987
SG - Singapore 8.233
CN - Cina 6.960
DE - Germania 3.622
IT - Italia 3.236
UA - Ucraina 3.064
BR - Brasile 2.952
TR - Turchia 2.287
HK - Hong Kong 2.177
GB - Regno Unito 1.585
SE - Svezia 1.129
VN - Vietnam 1.052
FI - Finlandia 1.024
RU - Federazione Russa 876
FR - Francia 453
PL - Polonia 414
MX - Messico 350
CA - Canada 344
IN - India 236
AR - Argentina 231
NL - Olanda 222
ID - Indonesia 178
ZA - Sudafrica 166
BD - Bangladesh 155
JP - Giappone 147
BE - Belgio 138
ES - Italia 116
EC - Ecuador 94
IQ - Iraq 78
LT - Lituania 78
CZ - Repubblica Ceca 77
AT - Austria 59
CO - Colombia 52
CL - Cile 51
VE - Venezuela 45
IR - Iran 39
PY - Paraguay 39
UZ - Uzbekistan 39
PK - Pakistan 36
AE - Emirati Arabi Uniti 35
MA - Marocco 32
SA - Arabia Saudita 29
AU - Australia 26
TN - Tunisia 25
JO - Giordania 24
KR - Corea 24
IL - Israele 23
IE - Irlanda 22
KE - Kenya 22
EU - Europa 21
EG - Egitto 19
RO - Romania 19
UY - Uruguay 17
PT - Portogallo 15
DZ - Algeria 14
BG - Bulgaria 13
NP - Nepal 13
PE - Perù 13
AL - Albania 11
KZ - Kazakistan 11
MY - Malesia 11
TW - Taiwan 11
CH - Svizzera 10
DO - Repubblica Dominicana 10
SN - Senegal 10
NO - Norvegia 9
PS - Palestinian Territory 9
CR - Costa Rica 8
HN - Honduras 8
JM - Giamaica 8
LV - Lettonia 8
PH - Filippine 8
AZ - Azerbaigian 7
BH - Bahrain 7
LB - Libano 7
OM - Oman 7
AM - Armenia 6
BO - Bolivia 6
MD - Moldavia 6
PA - Panama 6
TT - Trinidad e Tobago 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
BY - Bielorussia 5
CG - Congo 5
CI - Costa d'Avorio 5
ET - Etiopia 5
GR - Grecia 5
GT - Guatemala 5
HR - Croazia 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RS - Serbia 5
GA - Gabon 4
HU - Ungheria 4
MK - Macedonia 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
Totale 86.707
Città #
Singapore 4.752
Woodbridge 4.579
Ashburn 3.826
Fairfield 3.673
Jacksonville 3.295
Chandler 2.909
Houston 2.867
Ann Arbor 2.405
Hong Kong 2.169
Santa Clara 2.076
Beijing 2.034
Wilmington 1.658
Seattle 1.543
Dallas 1.481
Cambridge 1.157
Izmir 1.121
Nanjing 1.018
Princeton 711
Los Angeles 692
Munich 527
Boardman 524
Ferrara 452
Milan 421
New York 393
Ho Chi Minh City 365
Warsaw 362
San Diego 345
Nanchang 323
Shanghai 310
Shenyang 305
Falkenstein 290
São Paulo 263
Hefei 242
Mexico City 238
Tianjin 216
Hanoi 205
Hebei 204
Dearborn 203
Helsinki 198
Turku 194
Changsha 187
Bremen 182
San Mateo 176
London 174
Addison 170
Jiaxing 169
Chicago 142
Council Bluffs 138
Brussels 134
Tokyo 132
Buffalo 131
Frankfurt am Main 129
Jinan 126
The Dalles 124
Brooklyn 117
Falls Church 115
Zhengzhou 110
Jakarta 109
Montreal 106
Kunming 99
Rome 98
Moscow 96
Auburn Hills 94
Norwalk 94
San Francisco 92
Rio de Janeiro 91
Johannesburg 88
Toronto 86
Mountain View 85
Orem 84
Denver 83
Amsterdam 81
Guangzhou 81
Ningbo 80
Philadelphia 75
Phoenix 75
Chennai 74
Stockholm 74
Boston 71
Atlanta 68
Poplar 67
Bologna 66
Florence 66
Belo Horizonte 63
Düsseldorf 63
Orange 63
Redwood City 63
Manchester 59
Verona 57
Des Moines 53
Augusta 49
Haiphong 49
Ankara 48
Brasília 46
Dong Ket 46
Washington 45
Mumbai 43
Porto Alegre 43
Columbus 42
Curitiba 42
Totale 56.059
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.300
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.171
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 344
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 343
Pharmacology of Adenosine Receptors: The State of the Art 295
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 265
A glance at adenosine receptors: Novel target for antitumor therapy 261
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 252
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 236
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 235
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 226
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 220
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 218
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 218
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 217
The A3 adenosine receptor: history and perspectives 216
Adenosine receptors and human melanoma 215
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 213
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
Recettori e trasduzione del segnale 211
Recettori e trasduzione del segnale 210
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 210
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 210
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 209
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 209
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 205
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 205
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 204
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 203
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 201
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 200
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 200
Adenosine receptor targeting in health and disease 199
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 199
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 196
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 195
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 193
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 193
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 193
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 192
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 191
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 190
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 190
Adenosine signaling contributes to ethanol-induced fatty liver in mice 189
Ala scan analogues of HOE 140. Synthesis and biological activities 189
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 189
Current status of A1 adenosine receptor allosteric enhancers 188
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 188
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 187
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 186
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 183
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells 183
Adenosine receptors and cancer 183
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 183
7-nitro-1,3-dihydro-5-phenyl-1,4-benzodiazepin-2-one (nitrazepam) 183
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 182
van't Hoff Based Thermodynamics 182
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 180
Temperature dependence of [3H]PAF binding to washed human platelets 179
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 179
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 179
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 178
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 178
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 178
Pathological overproduction: the bad side of adenosine 178
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 177
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 176
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 176
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 176
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 176
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 175
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 175
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 174
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 174
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 173
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 173
Binding thermodynamics at A1 and A2A adenosine receptors 173
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 173
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 173
Totale 22.112
Categoria #
all - tutte 389.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.961
Totale 404.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.807 0 0 0 0 0 860 233 937 154 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/202513.457 395 383 1.062 633 1.646 1.192 406 904 1.847 1.522 1.911 1.556
2025/202620.251 3.833 1.684 3.942 4.949 5.365 478 0 0 0 0 0 0
Totale 87.413